| 000 | 01669 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516132642.0 | ||
| 264 | 0 | _c20140205 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1555-8576 | ||
| 024 | 7 |
_a10.4161/cbt.23623 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Angel, Rebecca E | |
| 245 | 0 | 0 |
_aStearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _cApr 2013 |
||
| 300 |
_a357-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 650 | 0 | 4 |
_aObesity _xphysiopathology |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aBlando, Jorge M | |
| 700 | 1 | _aHogan, Matthew G | |
| 700 | 1 | _aSandoval, Michael A | |
| 700 | 1 | _aLansakara-P, Dharmika S P | |
| 700 | 1 | _aDunlap, Sarah M | |
| 700 | 1 | _aHursting, Stephen D | |
| 700 | 1 | _aCui, Zhengrong | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 14 _gno. 4 _gp. 357-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.23623 _zAvailable from publisher's website |
| 999 |
_c22455968 _d22455968 |
||